XLRN

Acceleron Pharma Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

-42.88

p/bv

15.22

DIVIDEND YIELD

0.00%

XLRN price

Acceleron Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment XLRN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals XLRN

Valuation

P/E

-42.88

Sector -3.50

Industry -3.50

P/BV

15.22

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

Sector -214.99

Industry -214.99

EV/EBIT

Sector -47.59

Industry -47.59

P/EBITDA

-42.88

Sector -21.41

Industry -21.41

P/EBIT

-42.18

Sector -28.65

Industry -28.65

P/Total Assets

13.87

Sector 1.19

Industry 1.19

P/Net Current Assets

Sector -11.97

Industry -11.97

P/Working Capital

Sector -167.95

Industry -167.95

EPS

-4.17

Sector -1.81

Industry -1.81

BVPS

11.75

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

83.57%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-206.00%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-209.39%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.04

Sector 0.02

Industry 0.02

Profitability

ROE

-35.49%

Sector -56.04%

Industry -56.04%

ROA

-32.35%

Sector -60.31%

Industry -60.31%

ROIC

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

Sector -8.06

Industry -8.06

Net Debt / Equity

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

Sector -0.85

Industry -0.85

Equity/Assets

0.91

Sector 0.46

Industry 0.46

Liabilities/Assets

0.91

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

5.35%

Sector -

Industry -

5Y Earnings CAGR

5.24%

Sector -

Industry -

Fundamentals XLRN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
XLRN Acceleron Pharma Inc.	$0.00	-	0.00%	-42.88	15.22	-35.49%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

XLRN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Acceleron Pharma

Acceleron Pharma Inc.

Average Investor10 user rating

4.0 (0 people)

United States

23 years

Founded: 2003

2013

Time since IPO - 13 years

312

Employees

Acceleron Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $10.93 billion, with shareholders equity totaling $718.15 million.

The company employs approximately 312 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Acceleron Pharma Inc. reported $112.76 million in revenue, generating net income of $-254.85 million.

Key financial metrics include a P/E ratio of -42.88, a price-to-book (P/B) ratio of 15.22, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker XLRN.

Market cap

$10.93 billion

Net worth

$718.15 million

$718,153,000.00

Assets

$787.85 million

$787,848,000.00

Total Shares Outstanding

61.13 million

61,130,000

Average Daily Trading Volume

$1.59 million

$1,589,166.02

Sector

Health Care

Industry

Biotechnology

XLRN

XLRN revenue and profits

Financial Results XLRN

DRAG THE FRAME TO SEE MORE DATA

XLRN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Acceleron Pharma (XLRN) today?

A cotação de Acceleron Pharma (XLRN) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Acceleron Pharma (XLRN) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Acceleron Pharma (XLRN) e dados de ações do Ibovespa e mercados internacionais.

Quando Acceleron Pharma (XLRN) paga dividendos?

Acceleron Pharma (XLRN) não distribuiu dividendos no último ano.

Is Acceleron Pharma (XLRN) a good investment?

Atualmente, Acceleron Pharma (XLRN) está cotada a US$ 0.00, com um P/L de -42.88, representando um desvio de 0% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Acceleron Pharma (XLRN) stock?

Investir em ações de Acceleron Pharma (XLRN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Acceleron Pharma (XLRN) yield today?

A rentabilidade de Acceleron Pharma (XLRN) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Acceleron Pharma (XLRN) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

XLRN

Acceleron Pharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment XLRN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING XLRN WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Acceleron Pharma

Acceleron Pharma Inc.

United States

23 years

2013

312

Financial Results XLRN

XLRN cash flow

Asset, Revenue and Profit Growth - XLRN

XLRN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions